CSL Behring to Provide $80,000 in Scholarship Funding For Low-Income Students in Philadelphia Area

Company and Employees Cultivate a Culture of Giving, Including Partnering with Children's Scholarship Fund Philadelphia

News provided by

Mar 09, 2015, 09:00 ET

KING OF PRUSSIA, Pa., March 9, 2015 /PRNewswire/ -- CSL Behring announced that it is partnering with Children's Scholarship Fund Philadelphia (CSFP) to support scholarships for low-income students. CSL Behring will contribute $80,000 to fund scholarships in 2015 and 2016, enabling low-income students in grades K-8 to attend private and parochial schools that partner with CSFP.

CSL Behring employees take time out from their work day to package clothes, shoes, books, toys, baby safety equipment and school supplies for thousands of children in the Philadelphia area as part of the Cradles to Crayons program. Cradles to Crayons is one of many charitable programs supported by CSL Behring and its employees throughout the year.

Scholarship Fund boasts impressive success record
"Since its founding in 2001, Children's Scholarship Fund Philadelphia has awarded more than 16,500 four-year scholarships to K-8^th grade students," said Ina B. Lipman, CSFP Executive Director. "Scholarship recipients' on-time high school graduation rates are greater than 96 percent, well above their peers in public schools who graduate on time at a rate of about 57 percent, with a large majority unprepared to enter the workforce or college."

"We are grateful for partners like CSL Behring, who help to provide hope, opportunity and success to children from low-income families in our community. CSL Behring's dedication to providing youth in Philadelphia with financial access to a quality education is the key to improving our community and educating our future workforce."

Developing next generation of scientists and business leaders
Karen Etchberger, CSL Behring's Executive Vice President, Quality & Business Services, said the company and its employees are committed to supporting key programs in communities in which it operates. CSL Behring's operational headquarters is located in King of Prussia, Pa.

"Partnering with education-based organizations, like the Children's Scholarship Fund Philadelphia, sets a strong foundation for our future as a global biopharmaceutical company, helping prepare the next generation of scientists, researchers and leaders," said Etchberger.

The partnership is the latest in a host of philanthropic and outreach programs that are the foundation of CSL Behring's culture of supporting key community programs year-round.

Other 2014-2015 philanthropic and outreach highlights
The partnership with CSFP follows another record-breaking United Way campaign, which raised $787,000 across CSL Behring sites throughout the U.S.:

$243,000 was raised in CSL Behring's King of Prussia location for United Way of Greater Philadelphia and Southern New Jersey.
More than $411,000 was raised by CSL Plasma, a subsidiary of CSL Behring, and its employees for United Way chapters where the company's plasma collection centers are located;
$133,000 was raised by CSL Behring's manufacturing site in Kankakee, Ill.;
CSL Plasma raised $80,000 in a separate campaign for the Immune Deficiency Foundation.

Numerous other charitable works by CSL Behring employees in the past year contribute to the culture of giving.

Culture of giving is year-round
Etchberger emphasized that while CSL Behring and CSL Plasma generated the majority of funds for the United Way, employees gave many hours of their time, as well as monetary donations, supporting a host of other charities such as Big Brothers Big Sisters, Arthritis Foundation, Toys for Tots, Intrepid Fallen Heroes Fund, United2Feed, American Cancer Society and Ronald McDonald House, to contribute to the culture of giving.

About CSL Behring
CSL Behring is a leader in the plasma protein therapeutics industry. Committed to saving lives and improving the quality of life for people with rare and serious diseases, the company manufactures and markets a range of plasma-derived and recombinant therapies worldwide.

CSL Behring therapies are used around the world to treat coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease, and neurological disorders in certain markets. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn.

CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. CSL Behring is a global biopharmaceutical company and a member of the CSL Group of companies. The parent company, CSL Limited (ASX: CSL), is headquartered in Melbourne, Australia. For more information, visit http://www.cslbehring.com/.

Contact:

Chris Florentz, CSL Behring
610-878-4316
[email protected]

Photo - http://photos.prnewswire.com/prnh/20150306/180098
Logo - http://photos.prnewswire.com/prnh/20100914/PH63692LOGO

SOURCE CSL Behring